Aerpio Therapeutics Announces Presentation of Positive Results of AKB-9778 in Patients with Diabetic Retinopathy from TIME-2 Phase 2a Study. AKB-9778, a Tie2 activator, ...

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

Survival models using electronic health record data show promise in predicting progression to proliferative diabetic ...

Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of ...

If it’s left untreated, diabetic retinopathy can lead to serious, sight-stealing complications. Here’s what to know.

Non-proliferative diabetic retinopathy, or NPDR, is a form of diabetic retinopathy. NDPR occurs when diabetes damages small blood vessels within the retina. These vessels start to leak both fluid and ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a ...

Diabetic retinopathy occurs when high levels of blood sugar (a common marker of diabetes) damage the tiny blood vessels in the retina, a layer of tissue in the back of the eye that helps detect ...

A sensitivity analysis of those who had type 2 diabetes for at least 5 years showed that cataract surgery was tied to increased 1-year risks of PDR without complications (HR 1.52, 95% CI 1.06-2.19 ...

Fenofibrate use had a more pronounced impact on the risk of proliferative diabetic retinopathy, with a 24% decrease in progression (PDR; HR 0.76, 95% CI 0.64-0.90) but did not significantly affect ...